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Spontaneous self-assembly of amyloid b (1–40)
into dimers†
Mohtadin Hashemi, a Yuliang Zhang,ab Zhengjian Lvac and Yuri L. Lyubchenko *a
The self-assembly and fibrillation of amyloid b (Ab) proteins is the neuropathological hallmark of Alzheimer's
disease. However, the molecular mechanism of how disordered monomers assemble into aggregates
remains largely unknown. In this work, we characterize the assembly of Ab (1–40) monomers into
dimers using long-time molecular dynamics simulations. Upon interaction, the monomers undergo
conformational transitions, accompanied by change of the structure, leading to the formation of a stable
dimer. The dimers are stabilized by interactions in the N-terminal region (residues 5–12), in the central
hydrophobic region (residues 16–23), and in the C-terminal region (residues 30–40); with inter-peptide
interactions focused around the N- and C-termini. The dimers do not contain long b-strands that are
usually found in fibrils.
Introduction
The self-assembly of amyloidogenic proteins is related to several
neurodegenerative diseases.1–3 According to the amyloid
cascade hypothesis, self-assembly of amyloid b (Ab) is the
primary model for the development of Alzheimer's disease
(AD).1,4 The nal products of the amyloid self-assembly process
are brillar structures that contain long b-strands,5–7 whereas
Ab monomers are largely unstructured,8–10 which leads to the
question of how the conformational transition occurs during
self-assembly.
Recent compelling evidence show that amyloid oligomers
rather than brils are the most neurotoxic species.12–16 The
neurotoxicity of Ab oligomeric species have been attributed to
intracellular, membrane, and receptor-mediated mecha-
nisms.17–28 Various morphologies have been ascribed to oligo-
mers, from spherical aggregates to lamentous.29,30 It is
proposed that oligomers form the critical entities, called nuclei,
needed to transition to proto-bril states before nally bril-
lating.31 Spectroscopic characterization of Ab oligomers
revealed that they are composed of random coil secondary
structure, which is able to transition to b-structure as the
aggregation progresses.31–34 Sarkar et al. showed that the olig-
omer chemical shis are very different from brils, in particular
in the N-terminal and the central segment (residues 22–29).33
These nding are in line with the data from Ahmed et al., which
show that oligomers have disordered molecular
conformations.31
There are two principle alloforms of amyloid b proteins, Ab
(1–40) and Ab (1–42), dened by the number of residues; with
the former being the most abundant and the latter the most
aggregation prone and neurotoxic.35–41 Despite the small struc-
tural difference (two amino acids) between the Ab40 and Ab42
alloforms, they display distinct behavior, although the struc-
tural basis for this is unknown.38–42 Hence, a detailed charac-
terization of the oligomeric forms of these Ab species is
important for understanding neurotoxicity and pathology in
AD. Recent studies have demonstrated that single-molecule
approaches are powerful methods to study oligomers.43–46
Single-molecule techniques, such as AFM,11,47–51 tethered
approach for probing inter-molecular interactions (TAPIN),52,53
and FRET,33 have shown that the early-stage oligomers exhibit
prolonged lifetimes and stabilities. Novel features of the inter-
action and self-assembly of Ab40 and Ab42 peptides were
determined using single-molecule AFM-based force spectros-
copy.11 However, due to their transient nature and heteroge-
neity, many questions about the oligomer formation process
and the structure and dynamics of Ab oligomers are le
unanswered.54,55
Computational simulations have been utilized to supple-
ment the novel single-molecule techniques used to probe early
stages of aggregation and, in some cases, elucidate the
dynamics and mechanism of aggregation.50,56–60 Computational
studies of the dynamics of Ab42 lead to the discovery that, in an
aqueous environment, the protein mainly assumes a-helical
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structure.61 However, the helices are not stable and transition
between structured and unstructured conformations multiple
times. Further studies showed that Ab42 is more structured
compared to Ab40 and has a less exible C-terminal segment.57
These ndings are in line with the comparison of Ab40 and
Ab42 by Yang and Teplow, which showed that Ab42 forms more
stable conformations that tend towards b-structure and stable
C-terminus.62 More recent simulations have revealed that the
size and distribution of the early aggregates for Ab40 and Ab42
vary, the most common oligomer being dimers for the former
and pentamers for the latter.63,64 These results qualitatively
reproduce the main features of oligomer size distributions
measured experimentally.42,65 Furthermore, Ab42 displayed turn
and b-hairpin structures that are absent in Ab40.
Biased simulation strategies using a coarse-grained
approach has also been employed to investigate the aggrega-
tion pathway.66 Zheng et al. demonstrate that while pre-brillar
oligomers typically consist of antiparallel b-structure they are
distinct from brillar structures and very dynamic. These
structural characteristics are also demonstrated for the Ab40
dimer in the ndings of Tarus et al., which show that dimers are
compact conformations with inter-peptide antiparallel b-struc-
tures.67 Similar observations were also reported by Watts et al.
using a different force eld.68 However, how the structures of
oligomers contribute to neurotoxicity remain unclear. Leaving
the fundamental questions related to the mechanism of olig-
omer self-assembly and dynamics unanswered. Which, in turn,
has impeded the progress in the development of treatment for
these diseases.
We recently characterized the conformational changes in
monomers of Ab42 peptide upon dimer formation using long
time-scale all-atom molecular dynamics (MD) simulations.69
The simulations revealed that the dimer is very dynamic and
resulted in a multitude of different conformations being iden-
tied. By utilizing the recently developed Monte Carlo pulling
(MCP) approach,58 we were able to identify the most likely native
conformations of the Ab42 dimer, which generated statistically
similar dissociation forces and interaction proles as was
observed in AFM experiments.
Here, we applied the developed MD simulation strategy to
analyze the dimer formation of full-length Ab40 protein using
the special purpose Anton supercomputer.70,71 A variety of dimer
conformations were identied, all with small segments of
ordered structures and lacking the characteristic b-sheet
structures found in amyloid brils. These dimers structures
were then validated using MCP simulations and by comparing
with stability and interaction data obtained from AFM-based
force spectroscopy experiments. The validated dimer confor-
mations were then used to compare Ab40 and Ab42 dimers and
characterize the differences between the interaction of mono-
mers in the resulting dimers.
Simulation methods
Ab40 monomer simulation
To generate the initial structure of the monomer used for the
dimer simulation, we conducted all-atom MD simulations
using GROMACS ver. 4.5.5 (ref. 72) employing Amber ff99SB-
ILDN force eld73 and the TIP3P water model.74 The initial
monomer structure was adopted from NMR data8 (PDB ID:
1AML) with an extra N-terminal Cys residue added to mimic
experimental sequence.69 The monomer was then solvated,
neutralized with NaCl ions, and kept at 150 mM NaCl concen-
tration. Following which energy minimization was performed,
before 500 ns NPT (isothermal–isobaric ensemble) MD simu-
lation, at 1 bar and 300 K, was carried out.
Spontaneous dimerization of Ab40
The initial Ab40 dimer conformations were prepared in the
Maestro soware package (Schrödinger, New York, NY), using
the same force eld and water model as for the monomer MD
simulation. Dimer conformations were created by placing two
copies of the representative monomer, cluster 1 in Fig. S1,† at
4 nm center of mass (CoM) distance. Two congurations were
created, parallel and orthogonal (90! rotation between the two
monomers with respect to the long peptide axes). The dimers
were then solvated, neutralized, and NaCl concentration kept at
150 mM; aer which they underwent energy minimization and
50 ns NPT simulation to relax the systems. They were then
submitted for 4 ms MD simulation on the special purpose
supercomputer Anton.
Accelerated MD simulations
To extend conformational sampling, dimer structures obtained
from the MD simulations on Anton were subjected to the
accelerated MD (aMD) simulation method. The simulation
procedure was adopted from the description by Pierce et al.75
and the website (URL: http://ambermd.org/tutorials/advanced/
tutorial22/) using Amber 14 soware package.76 Briey, dimer
conformations from the last frame of the MD simulation on
Anton and from the two lowest energy minima were solvated,
neutralized, and kept at 150 mM NaCl, and energy minimized,
before being submitted for 500 ns aMD simulations. Simula-
tions utilized the same force eld and water model as previous
simulations.
Monte Carlo pulling simulations
The Monte Carlo pulling method was performed to simulate
AFM force spectroscopy experiments using our previously
described procedure58 and a modied PROFASI package.77
Briey, the two Ca of the N-terminal Cys residues of each
monomer were dened as the pulling groups. A virtual spring
was attached onto each pulling group and used to stretch them
during the pulling process. The energy dynamics of the spring
were calculated using the A2A spring function (PROFASI
package) with the total energy during the course of pulling
described by,
Etot ¼ EðxÞ þ
k
2
½L0 þ vt' LðxÞ(
2 (1)
where E(x) describes the energy without an external force, k and
t are the spring constant of the virtual spring, and L0 is the
initial distance between the two Ca atoms. L(x) represents the
















































































































real-time distance between the Ca atoms while x denotes the
protein conformation being probed. When v¼ 0.083 fm per MC
step, it mimics the pulling speed of 500 nm s'1; which was used
for all MCP simulations.
Analysis methodology
Cluster analysis was performed using the GROMOS method of
clustering and root-mean square deviation (RMSD) as input for
the protein backbone, as previously described.50 To remove
rotational and translational motion of the backbone, atoms
were centered in the box and t using the progressive method of
trjconv.
We monitored secondary structure dynamics according to
the method developed by Thirumalai's group.78 Briey, if the
dihedral angles from two consecutive residues satisfy the de-
nition of an a-helix ('80! # f# '48! and'59! # j#'27!) or
b-strand ('150! # f#'90! and 90! # j# 150!), the structures
are considered to be a or b conformations, respectively. The











bsðsÞds, where t ¼ s
and D ¼ 1 ns. When the residues adopt a- or b-conformations,
the di,a ¼ 1 or di,b ¼ 1.
The principal component analysis of backbone dihedrals
(dPC)79 was used to generate the energy landscape and identify
the representative structures of the minima. The Fortran
program79 written by Dr Yuguang Mu was used to perform this
analysis.
Intra-peptide contact probability maps were generated based




We performed all-atom MD simulations of Ab40 monomers to
identify the most representative monomer structure. We adop-
ted the approach from our recent simulations of the Ab42
dimer.69 Briey, the Ab40 monomer structure was simulated for
500 ns, the most representative structure was then identied
using cluster analysis. The results of the cluster analysis are
shown in Fig. S1.† Twelve clusters were identied, with the 1st
cluster comprising 47.5% of the entire population. The repre-
sentative structure of this cluster contains a large a-helical
segment in the central region of the peptide and is otherwise
unstructured. Two copies of this structure were used to char-
acterize the dimer conformation.
Characterization of Ab40 dimer formation
Two dimer systems were generated by placing copies of the
monomer structure in orthogonal (90!) or parallel orientations,
with respect to the long peptide axis, at 4 nm CoM distance,
Fig. 1 right column. Both dimer conformations were then
simulated for 4 ms on the Anton supercomputer.
To determine if the dimer simulations had converged, we
monitored the time-dependent change in secondary structure
of the peptides, Fig. 1 le column. The graphs show that for the
orthogonal conguration, a-helical content uctuates with
a decreasing tendency up to the 1 ms mark, aer which the
helical portion increases over the next 1 ms span, Fig. 1a.
Meanwhile, the b-content remains stable at approximately 5%,
with minor uctuations, until approximately 3.5 ms; aer which
a conversion from a-helical to b-structure is observed, with b-
content reaching a maximum of )12% at the end of the simu-
lation. For the parallel conguration on the other hand, both a-
helical to b-structure content uctuate throughout the simula-
tion, with averages of approximately 15% and 5%, respectively,
Fig. 1b. This suggests that, for both congurations, a local
equilibrium state has not been reached.
The free energy landscape of the dimer was generated using
dihedral principal component analysis, Fig. S2.† For both dimer
congurations, several distinct energy minima were found.
Furthermore, both congurations show a rough and discon-
tinuous energy landscape. This, in combination with the time-
resolved change in secondary structure, suggests that the
dimers are trapped in local energy minima, leading to insuffi-
cient sampling of the conformational space. To overcome this
problem and to enhance the sampling of the conformational
space, we extended the dimer simulation using accelerated MD
simulations (see specics in Methods) allowing us to potentially
reach sampling enhancement by several orders of magnitude.75
Accelerated MD simulations of dimers
The energy landscapes from the aMD simulations of the dimer
are presented in Fig. S3.† Several well-dened and separated
energy minima were identied for the orthogonal system,
Fig. S3a,† while the parallel system only has few energy minima
that are clustered in the same region of the energy landscape,
Fig. S3b.† It is clear from the energy landscape that a larger
portion of the conformation space was sampled during aMD
simulation. The results were then pooled and the concatenated
data set (3 ms total) underwent dPC analysis again, Fig. 2 top.
The snapshots in the gure depict representative structures
Fig. 1 Time-resolved change in protein secondary structure during 4
ms all-atom MD simulations of Ab40 dimers in the orthogonal (a) and
parallel (b) starting configurations. Red and blue depict data using
a running average filter. Right column shows a snapshot of the initial
structures for each system.
















































































































from the two lowest energy minima. It is evident, that the dimer
does not adopt long b-structures but has a mixture of short
helices and b-structures.
The secondary structure of the dimers was characterized
using DSSP.80 Each monomer was investigated separately with
the results being displayed as residue specic probabilities,
Fig. 2 bottom. Monomer 1 shows greater than 40% propensity
for helix formation in residues 3–7, 11–13, and 25–29. b-Struc-
tures are overall less likely compared to helices, however regions
10–30 and 35–38 have on average greater than 20% chance of b-
structures. Monomer 2 on the other hand is more diverse, the
helix probability is localized around residues 11–20, while
collectively b-structures are more probable in the N- and C-
terminal segments in residues 3–10 and 21–38, respectively.
To analyze the conformational diversity of the dimers we
performed cluster analysis using the pooled aMD data. Similar
to the analysis performed for monomers, clustering was per-
formed using RMSD of backbone atoms between all pairs of
structures with a cut-off at 4.5 Å. Representative structures for
the rst 20 clusters are depicted in cartoon representation and
relative populations on Fig. 3. Structurally the clusters, with few
exceptions, exhibit similar trends of low a-helical and b-struc-
tural content and high degree of unstructured regions. This is
also evident from DSSP of the representative structures, Table
S1.† Further characterization reveal that the dimers are very
similar geometrically, having gyration radii and volume within
a few % of each other, Table S1.† However, the structures show
larger variability in the solvent accessible surface area (SASA),
ranging from )50 to 60 nm2. The main difference within the
clusters arise from the different congurations of monomers.
To identify segments important for the interaction of Ab40
monomers, we performed analysis of the pair-wise residue
interactions. Intra-peptide contact probability maps were gener-
ated based on Ca atom contacts within the monomers, Fig. S4.†
For monomer 1, interactions in three segments stand out, resi-
dues 5–12, residues 16–23, and residues 30–40, Fig. S4a.† The
interactions within these three segments reveal that the mono-
mer during the simulations, with high probability, is found in
a compact turn-like conformation with C-terminal interacting
with the central segment of the peptide. Monomer 2 on the other
hand ismore dynamic with few residues interacting within the N-
terminal region and the 16–23 segment, Fig. S4b.† The interac-
tion patterns of the two monomers reveal that, apart from
neighbor residue interactions, the main difference is found in
the way the two monomers interact with the 16–23 region; for
monomer 1 the interaction happens with residues 33–38, while
for monomer 2 it is residue 28–32, Fig. 4a.
The inter-peptide interactions of the dimer were obtained
using the pair-wise interactions of Ca atom between the
monomers, Fig. 4b. The contact map reveals that the interac-
tions between the two monomers occur in the central region of
the peptide as well as between the N- and C-terminals and the
two C-termini. Comparison of the contact data and the dimer
structures, revealed by cluster analysis on Fig. 3, shows that the
20 most populated clusters are a mixture of different confor-
mations that all contain N–C terminal interactions, with a few
congurations also containing C–C terminal interactions.
Fig. 2 Analysis of Ab40 dimers obtained from 3 ms aggregate accel-
erated MD simulations. Top, free energy landscape based on dihedral
principle component analysis of Ab40 dimers; the two lowest energy
structures are shown as cartoons. Blue depict monomer 1 while red is
monomer 2. Bottom, probability of each secondary structure type,
determined by DSSP, for each monomer within the Ab40 dimer, on
a per residue basis.
Fig. 3 Cluster analysis of Ab40 dimers obtained from 3 ms aggregate
accelerated MD simulations. Representative structures of the top 20
clusters formed by Ab40 dimers are presented with relative pop-
ulations, as percent, for each cluster displayed below each structure.
a-Helices are colored blue while b-strands are in red. A solid sphere
depicts the N-terminal Ca.
















































































































Monomer 1 primarily interacts through its central and C-
terminal segments, while monomer 2 interacts through the N-
and C-terminal regions.
Validation of dimer conformations
To validate the simulation results, as well as identify the
experimentally relevant conformations, we used the Monte
Carlo pulling approach to simulate AFM pulling experiments
and to compare the simulated results with experimental data.11
The rupture force and interaction patterns for the top candi-
dates are presented in Fig. 5. The interaction patterns of the
simulated dissociation processes were normalized with respect
to the experimentally obtained contour lengths. Experimentally
observed values for the dissociation force was 56.6 * 20.5 pN
(STD), approximated using a Gaussian distribution, with a two-
peak distribution of the interaction pattern favoring interaction
in the N-terminal and central regions.11
The dimer obtained following analysis of the MD simula-
tions on Anton (Fig. S2†), named “MD” on Fig. 5, shows
a distinct three-peak interaction pattern, with majority of
interactions located in the N-terminal and central regions of the
proteins, while the dissociation force is 36.5 * 18.4 pN. Dimer
conformations from the two most populated clusters (cluster 1
and cluster 2) from Fig. 3 (following the aMD simulations)
produce rupture forces of 61.7 * 27.5 pN and 35.6 * 17.7 pN,
respectively. Similar to the MD dimer, the two aMD conforma-
tions produce the distinct three-peak interaction pattern.
However, cluster 1 shows a very large C-terminal peak. However,
the dissociation of dimer cluster 1 is statistically similar to the
experimentally observed results, using a non-parametric two-
sample Kolmogorov–Smirnov with 0.05 signicance.
To characterize the interaction pattern and the dissociation
force of a dimer (within brils) with high b-structure content,
we created two dimer conformations from NMR structures of
Ab40 brils with different morphologies (PDB IDs: 2LMN (wild-
type) and 2MVX (Osaka mutant)). The dissociation patterns for
the two bril dimers are signicantly different compared to
experimental results and the results obtained for the MD and
aMD dimers, Fig. S5.† Although, the bril dimers contain the
three-peak interaction pattern, the patterns are signicantly
different; for the 2LMN dimer the majority of interactions
happen within the central part of the dimers, while for 2MVX
dimer the interactions are dominated by the N- and C-
terminals.
Fig. 4 Analysis of peptide interactions of Ab40 dimers from 3 ms aggregate acceleratedMD. (a) The difference in the contact probability between
the two monomers and (b) the inter-peptide contact probability map for Ca atoms of dimers.
Fig. 5 Force-induced dissociation results for Ab40 dimers obtained
from experiment (from ref. 11) and MCP simulations. Each dataset
shows a scatter plot of normalized distance vs. force, a histogram of
force (blue), and a histogram of normalized distance (red); normali-
zation was performed based on the experimentally observed contour
lengths. Peak values, obtained using Gaussian distribution function, are
presented above each peak of the histogram. Cluster 01 and 02 are
conformations from Fig. 3, while “MD” is the most populated cluster
following MD simulation. Statistical analysis was performed using two-
sample Kolmogorov–Smirnov test with 0.05 significance level; only
cluster 01 was statistically similar to the experimental data set, with p >
0.066.

















































































































Although the behavior of Ab peptides have been subject to
numerous studies, our present study presents a number of new
features about the Ab40 dimers. The equilibrated monomer
structure, used as the initial conformation to characterize the
dimerization process, is in line with recent data obtained using
NMR and simulations of the Ab proteins, which showed that the
monomer has unstructured segments and can assume helical
secondary structure.10,81 Another interesting feature of the
monomer structure is the presence of a turn on each side of the
central helix, the turn conformation is believed to be the rst
folding event in the structural transition of Ab proteins and
important for the aggregation process.5,82,83
Our computational analysis of the aggregation of Ab40 into
dimers reveal a broad range of peptide structures and very
dynamic feature of the dimers. In particular, we did not identify
signicant b-conformation in the monomers within the dimer,
Fig. 3. The interaction of two monomers lead to conformational
transitions within themonomers, accompanied by change in local
structure of the peptides, leading to the formation of a stable
dimer. Investigation of the dimer structures showed that the Ab40
dimers exhibit a heterogeneous ensemble of conformations that
contain a diverse number of structures. Dimers are stabilized by
interactions in the N-terminal region (residues 5–12), in the
central hydrophobic region (residues 16–23), and in the C-
terminal region (residues 30–40); with inter-peptide interactions
focused around the N- and C-terminals. The 20 most populated
clusters are a mixture of different conformations that all contain
N–C terminal interactions, with a few congurations also con-
taining C–C terminal interactions. Similar observations regarding
the interaction pattern of Ab40 dimers have been presented by
Tarus et al.84 The authors showed that regions, identied in our
simulations, were also interacting and important for the stability
of the dimer. However, unlike the dimer conformations identied
here, their dimers contained signicant b-structure content. More
recent ndings from the same group85 show that the dimers
structures are more diverse and do not contain a large extent of b-
structure, and that the dimer is stabilized by nonspecic interac-
tions. The low b-structure content is in agreement with our nd-
ings, and also can explain the role of structural plasticity in the
interactions of Ab oligomers with binding partners and ultimately
their toxicity. The structural exibility of the dimer may also play
a role in the aggregation progression, where the free energy cost of
transitioning from less ordered states is much less compared to
dimeric states with high level of ordered b-structures.
We validated the dimer conformations using MCP approach to
simulate the force-induced dissociation of the dimers and
compared the obtained force and interaction patterns with
experimental results. The simulations were performed at condi-
tions identical to the experimental ones11 and allowed us to
identify the dimer conformation of cluster 01 as themost probable
dimer probed during experiments. Probing of dimer conforma-
tions with high degree of b-structure content, adopted from bril
structures, showed that such dimers produce dissociation forces
signicantly different compared to experiment as well as our
simulated dimers. Furthermore, the interaction pattern of high b-
content dimers was strongly shied compared to experiments.
Comparing the Ab40 dimer with the Ab42 dimer, analyzed in
our recent publication,69 shows that the Ab42 dimer is stabilized
by interactions in the central region (residues 16–23) between
the two monomers as well as C–C terminal interactions through
residues 30–36 and 36–42. Interactions also occur between the
N-termini of the two monomers. Suggesting that the two extra
C-terminal amino acids of Ab42 affects the spatial orientation
within the dimer as well as the inter-peptide interaction pattern
of the monomers. These nding are in line with recent nding
about the monomeric Ab peptides,81 which show that while the
two alloforms show similar structural elements, their confor-
mations are different and that in turn has a large effect on the
inter-molecular interactions of the peptides.
Conclusions
All-atom MD simulations allowed us to structurally characterize
Ab40 dimers. Structures were organized in clusters, with )54%
represented in the 20 most populated clusters. Dimers are stabi-
lized by interactions in the central hydrophobic region (residues
17–21) as well as N–C terminal interactions (residues 1–10 and 30–
40), through hydrophobic interactions and H-bonds. Ab40 dimer
did not show parallel in-register b-sheet structures, as one may
expect based on the known structures of Ab brils. Comparison of
Ab40 to Ab42 dimers revealed differences in their conformations.
Ab40 dimers are stabilized primarily by interactions within the
central hydrophobic regions and the N-terminal regions, whereas
Ab42 dimers are stabilized by interactions in the central and C-
terminal regions. Ab40 dimers are more dynamic compared to
Ab42 dimers. Comparison, based on MCP simulations, between
Ab40 and Ab42 showed that overall, the dimers of both alloforms
exhibit similar interaction strengths. However, the interaction
maps, andmore importantly the patterns, clearly show differences.
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